Company intelligence / Profile preview

OrigiMed

Shanghai, Shanghai, Chinaorigimed.com ↗

Ownership: Private
Development stage: Commercial

Overview

OrigiMed provides comprehensive genomic profiling and molecular diagnostic services to support personalized cancer therapy decisions. The company collaborates with pharmaceutical companies to enable new drug development using real-world datasets. It has received CAP accreditation for its laboratories and has established partnerships with major pharma companies such as Bayer, Takeda, Menarini, and Illumina. Clinical results are not directly applicable since it is not developing therapeutics but rather enabling targeted therapy selection through advanced diagnostics.

Therapeutic areas: Oncology
Modalities: Molecular diagnosticsGenomic testingCompanion diagnostics
Industry: Molecular Diagnostics

Partnerships

BayerTakeda Pharmaceutical Company LimitedMenarini GroupIllumina Inc.

Beyond the preview

Go deeper on OrigiMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrigiMed.

Explore the full profile